Bumper Offer - Urjas oil Just @ Rs. 1
Metolar AM 50 Tablet is a commercial drug that is prescribed in the form of Tablet. Secondary and off-label uses of Metolar AM 50 Tablet have also been mentioned below.
The optimal dosage of Metolar AM 50 Tablet is largely dependent on the individual's body weight, medical history, gender and age. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. For detailed information on this, read through the dosage section.
The most common side effects of Metolar AM 50 Tablet are Slow heart rate (pulse). Besides the aforementioned side effects, there are other adverse effects of Metolar AM 50 Tablet as well, which are listed below. These side effects of Metolar AM 50 Tablet are usually temporary and subside with the completion of treatment. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Metolar AM 50 Tablet has a Severe effect for pregnant women and Mild effect on lactating mothers. It is important to know if Metolar AM 50 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Metolar AM 50 Tablet related warnings section.
Metolar AM 50 Tablet can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Metolar AM 50 Tablet in conditions like Low Blood Pressure (Hypotension), Coronary Artery Disease (CAD), Liver Disease. Other contraindications of Metolar AM 50 Tablet have been discussed in the sections ahead.
Additionally, Metolar AM 50 Tablet may also adversely react with other medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Metolar AM 50 Tablet is considered not safe while driving, and is not addictive.
Metolar AM 50 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when Metolar AM 50 Tablet is used -
Moderate
Mild
Common
Is the use of Metolar AM 50 Tablet safe for pregnant women?
Metolar AM should not be taken during pregnancy, or should only be taken on the advice of a doctor as it may have severe side effects.
Is the use of Metolar AM 50 Tablet safe during breastfeeding?
Side effects of Metolar AM for breastfeeding are little to none, so you can take it without doctor's advice.
What is the effect of Metolar AM 50 Tablet on the Kidneys?
Metolar AM is not harmful for kidneys.
What is the effect of Metolar AM 50 Tablet on the Liver?
Metolar AM has very mild side effects on the liver.
What is the effect of Metolar AM 50 Tablet on the Heart?
Metolar AM is rarely harmful for the heart.
Metolar AM 50 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Metolar AM 50 Tablet unless your doctor advises you to do so -
Is this Metolar AM 50 Tablet habit forming or addictive?
No, you will not get addicted to Metolar AM 50 Tablet.
Interaction between Food and Metolar AM 50 Tablet
Taking Metolar AM 50 Tablet with some specific foods may delay its effect. Talk to your doctor about this.
Interaction between Alcohol and Metolar AM 50 Tablet
Taking Metolar AM 50 Tablet with alcohol can have severely harmful effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lopressor (metoprolol tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 148-149
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 847-850
